Plenary Speakers

Monday, July 31 | 9:00 - 10:00

Wearable sensors have received a major recent attention owing to their considerable promise for monitoring the wearer’s health and wellness [1-3]. This presentation will discuss our recent efforts towards developing wearable bioelectronic systems, capturing non-invasively molecular information, for obtaining comprehensive information about the wearer health, nutrition and wellness. Particular attention will wearable electrochemical sensors integrated directly on the epidermis or under the skin for continuous monitoring of sweat and ISF, and to multimodal devices fusing the monitoring of chemical and physical parameters on a single epidermal patch. The preparation, characterization and applications of such skin-worn bioelectronic platforms will be described, along with related energy and integration advances, and future prospects and challenges.

Tuesday, August 1 | 9:00 - 10:00

Recent technological advances in microfabrication techniques and the development of new biological model systems have enabled the realization of microphysiological systems capable of recapitulating aspects of human physiology in vitro with great fidelity. Using microfluidic, microtechnological and microsensor structures and representative in vitro models of human organs, robust microphysiological systems can be developed that accommodate high-resolution microscopy and integrated biosensor readouts. Combination of multiple organs and integrated sensor modalities in different specific applications will be presented.

The potential and emerging role of biosensors and their application in the field of infectious diseases will be discussed. The opportunity to improve and inform the prevention, identification, management, and treatment of infectious diseases in a range of contexts is immense. The contribution to improved healthcare through the innovative application of sensors in research, observational studies, and behavioural change will also be considered. Opportunities provided by applying sensor technologies to enable the optimising of antimicrobial use will both improve clinical outcomes and contribute to global efforts to minimise antimicrobial resistance (AMR) and drug resistant infection.